Investigation of the Pharmacokinetics and Metabolism of GLPG0634 in Healthy Male Subjects

NCT01820806 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 100 mg dose of [14C] GLPG0634

Sponsor

Lakefront Biotherapeutics NV